Stopping the medication could be risky during pregnancy, but there is more to the story to be uncovered ...

The study is part of the Infant Development Environment and Lifestyle (IDEAL) Study, a multi-site, longitudinal study of prenatal MA exposure and infant and childhood outcomes. The IDEAL study ...

A new study suggests that stopping GLP-1 medications before pregnancy may be linked to higher rates of complications and gestational weight gain. Experts caution that the findings don't prove ...

A new study shows stopping GLP-1 weight loss drugs before or early in pregnancy may increase risks of weight gain, diabetes, high blood pressure, and preterm birth. Learn why these medications aren’t ...

Researchers said more should be done to weigh the pros and cons of taking weight loss drugs around the time of pregnancy. View on euronews ...

GLP-1 agonist drugs essentially mimic the hormone’s action. Quite a few have been developed, including semaglutide, ...

By Dr. Liji Thomas, MD New research shows that women who halt GLP-1 medications near conception face greater gestational weight gain and elevated risks for preterm birth and pregnancy-related ...